JSR Life Sciences 新闻与活动

JSR Life Sciences由JSR所有。

JSR 是一家在股票代码 4185 (JP) 下上市的公司。

JSR 在 3 个国家有直接业务。

JSR 拥有 5家子公司，其中包括 Crown Bioscience、Indivumed Services 和 Inpria。

他们在：

• 生物技术67%
• 化学17%
• 其他17%

查看带有其 37 名主要高管的组织结构图

JSR Life Sciences 搜索最多的简介

• Hideaki Nomura, Chief Executive Officer
• Yuanxin Zhang, Head, Corporate Venture Fund
• Hiroki Itou, General Manager, Diagnostic and Research Reagents

高管在JSR变化

• Eric Johnson 曾任 Representative Director and Chief Executive Officer, 将于 20254月1 现任 Director  (新闻发布的2025三月26号).
• Tetsuro Hori 曾任 Vice President, Chief Financial Officer, Chief Legal Officer and Director, 将于 20254月1 升职为 President, Chief Executive Officer and Representative Director  (新闻发布的2025三月26号).

创建提醒
跟踪 JSR Life Sciences 的高管变动

JSR 拥有 2,350 家竞争者，其中包括 Astellas Gene Therapies (美国(美洲))、Eurofins (卢森堡) 和 Lonza (瑞士)。

Popular M&A news in 生物技术

• Eli Lilly has announced the acquisition of Verve Therapeutics  (公布2025六月17号).
• Sirius Therapeutics 刚刚宣布为 50 筹款数百万美元。 (公布2025六月16号).
• BioNTech has announced the acquisition of CureVac  (公布2025六月12号).

生物技术 行业的其他推荐联系人

• WIRB-Copernicus Group 企业 Sandra Smith - Senior Vice President, Clinical Solutions & Strategic Partnerships
• Keros Therapeutics 企业 Jasbir Seehra - Chief Executive Officer and Chairman of the Board
• Wheeler Bio 企业 Deepika Verma - Associate Director of Data Science and Digitalization

了解更多有关生物技术行业的信息

JSR Life Sciences 的最新新闻稿

• JSR Life Sciences 新闻中心
• Crown Bioscience Wins 2024 Fierce CRO Award for Excellence in Client Service and Partnership
• Crown Bioscience Wins BioTech Breakthrough Award for Drug Development Innovation
• Prostate Cancer Breakthrough: Crown Bioscience Collaborates in €1.75M Eurostars Funded Project for Novel Liquid Biopsy Test
• Crown Bioscience Expands Singapore Facility with Advanced Oncology Models and Imaging Capabilities
• JSR Life Sciences to Launch Amsphere™ A+, a Next-Generation Protein A Resin for Antibody Drug Purification
• Crown Bioscience Partners with CTI to Support Consulting Services in Oncology Drug Development
• Following a Successful FDA Inspection, KBI Biopharma Extends and Expands Commercial Contract with Leading Global Pharmaceutical Company
• Innovation Funding and Crown Bioscience: Collaborating to Discover the Next Wave of Oncology Therapies
• Crown Bioscience Enters Global Agreement with Shanghai Model Organisms Center
• View more press releases Close

关于 JSR Life Sciences 的社交媒体

• JSR Life Sciences 在 维基百科、谷歌新闻 和 雅虎财经
• JSR Life Sciences 在 LinkedIn、叽叽喳喳 和 YouTube